Improving Compliance With Metformin - Full Text View

Improving Compliance With Metformin

This study has been completed.

Sponsored by:	Department of Veterans Affairs
Information provided by:	Department of Veterans Affairs
ClinicalTrials.gov Identifier:	NCT00018616

Purpose

This is a randomized controlled trial of adherence. The study involves monitoring and managing focused intervention in patients prescribed metformin.

Condition	Intervention	Phase
Diabetes	Behavioral: MEMS caps	Phase II

Drug Information available for:

Metformin Metformin hydrochloride

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study

Official Title:	Improving Compliance With Metformin

Further study details as provided by Department of Veterans Affairs:

Study Start Date:	October 1999
Estimated Study Completion Date:	February 2002

Detailed Description:

The active intervention, MEMS Feedback, involves review of patients' medication-taking over the preceding weeks

Eligibility

Criteria

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00018616

Locations


United States, Connecticut
	VA Connecticut Healthcare System
	West Haven, Connecticut, United States, 06516

Sponsors and Collaborators

Department of Veterans Affairs

Investigators


Investigator:	Michael Rigsby, M.D.

More Information

Study ID Numbers:	MHBS-047-98F
First Received:	July 3, 2001
Last Updated:	June 23, 2005
ClinicalTrials.gov Identifier:	NCT00018616
Health Authority:	United States: Federal Government

Keywords provided by Department of Veterans Affairs:

metformin

compliance

MEMS

Study placed in the following topic categories:

Metformin

Diabetes Mellitus

Additional relevant MeSH terms:

Hypoglycemic Agents

Physiological Effects of Drugs

Pharmacologic Actions

ClinicalTrials.gov processed this record on November 20, 2008